Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo

被引:91
作者
Al Rashid, ST
Dellaire, G
Cuddihy, A
Jalali, F
Vaid, M
Coackley, C
Folkard, M
Xu, Y
Chen, BPC
Chen, DJ
Lilge, L
Prise, KM
Jones, DPB
Bristow, RG
机构
[1] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[3] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[4] Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada
[5] Mt Vernon Hosp, Gray Canc Inst, Northwood HA6 2RN, Middx, England
[6] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA
[7] Univ Texas, SW Med Ctr, Div Mol Radiat Biol, Dept Radiat Oncol, Dallas, TX USA
关键词
D O I
10.1158/0008-5472.CAN-05-0729
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite a clear link between ataxia-telangiectasia mutated (ATM)-dependent phosphorylation of p53 and cell cycle checkpoint control, the intracellular biology and subcellular localization of p53 phosphoforms during the initial sensing of DNA damage is poorly understood. Using GO-G, confluent primary human diploid fibroblast cultures, we show that endogenous p53, phosphorylated at Ser(15) (p53(Ser15)), accumulates as discrete, dose-dependent and chromatin-bound foci within 30 minutes following induction of DNA breaks or DNA base damage. This biologicafly distinct subpool of p53(Ser15) is ATM dependent and resistant to 26S-proteasomal degradation. p53(Ser15) colocalizes and coimmunoprecipitates with gamma-H2AX with kinetics similar to that of biochemical DNA double-strand break (DNA-dsb) rejoining. Subnuclear micro-beam irradiation studies confirm p53 S,,15 is recruited to sites of DNA damage containing gamma-H2AX, ATM(Ser1981), and DNA-PKcs(Thr2609) in vivo. Furthermore, studies using isogenic human and murine cells, which express Ser(15) or Ser(18) phosphomutant proteins, respectively, show defective nuclear foci formation, decreased induction of p21(WAF) decreased gamma-H2AX association, and altered DNA-dsb kinetics following DNA damage. Our results suggest a unique biology for this p53 phosphoform in the initial steps of DNA damage signaling and implicates ATM-p53 chromatin-based interactions as mediators of cell cycle checkpoint control and DNA repair to prevent carcinogenesis. (Cancer Res 2005; 65(23): 10810-21).
引用
收藏
页码:10810 / 10821
页数:12
相关论文
共 61 条
[1]   Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation [J].
Ali, A ;
Zhang, J ;
Bao, SD ;
Liu, I ;
Otterness, D ;
Dean, NM ;
Abraham, RT ;
Wang, XF .
GENES & DEVELOPMENT, 2004, 18 (03) :249-254
[2]   Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair [J].
Alt, JR ;
Bouska, A ;
Fernandez, MR ;
Cerny, RL ;
Xiao, H ;
Eischen, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) :18771-18781
[3]  
Andegeko Y, 2001, J BIOL CHEM, V276, P38224
[4]   DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation [J].
Bakkenist, CJ ;
Kastan, MB .
NATURE, 2003, 421 (6922) :499-506
[5]  
Banáth JP, 2003, CANCER RES, V63, P4347
[6]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[7]   Direct evidence for a bystander effect of ionizing radiation in primary human fibroblasts [J].
Belyakov, OV ;
Malcolmson, AM ;
Folkard, M ;
Prise, KM ;
Michael, BD .
BRITISH JOURNAL OF CANCER, 2001, 84 (05) :674-679
[8]   Role of PML and the PML-nuclear body in the control of programmed cell death [J].
Bernardi, R ;
Pandolfi, PP .
ONCOGENE, 2003, 22 (56) :9048-9057
[9]   Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage [J].
Bradshaw, PS ;
Stavropoulos, DJ ;
Meyn, MS .
NATURE GENETICS, 2005, 37 (02) :193-197
[10]   Resistance to DNA-damaging agents is discordant from experimental metastatic capacity in MEF ras-transformants-expressing gain of function MTp53 [J].
Bristow, RG ;
Peacock, J ;
Jang, A ;
Kim, J ;
Hill, RP ;
Benchimol, S .
ONCOGENE, 2003, 22 (19) :2960-2966